Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Top 25 Pharma and Biopharma Report | Contract Pharma

What are you searching for?

Sign in
Features

Top 25 Pharma and Biopharma Report

Based on 2015 Sales, in $U.S. Million

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma


1. Novartis $49,414
2. Pfizer $48,851
3. Sanofi $40,486
4. Merck & Co. $39,498
5. Roche $37,667
6. GlaxoSmithKline $35,463
7. Gilead $32,639
8. Johnson & Johnson $31,430
9. AstraZeneca $24,708
10. AbbVie $22,859
11. Amgen $21,662
12. Eli Lilly & Co. $19,958
13. Teva $19,652
14. Bristol-Myers Squibb $16,560
15. Boehringer Ingelheim $16,167
16. Takeda $16,068
17. Novo Nordisk $15,801
18. Allergan $15,071
19. Bayer $15,017
20. Merck KGaA $14,034
21. Otsuka $11,993
22. Biogen $10,764
23. Mylan $9,363
24. Celgene $9,256
25. Daiichi Sankyo $8,770


Contributors

Editor: Tim Wright
Associate Editor: Kristin Brooks

All profiles compiled by Tim Wright, except Gilead, Amgen, Boehringer-Ingelhaim and Biogen, by Kristin Brooks Pipeline/revenue information compiled by Kristin Brooks


*Profile information is sourced from each company’s annual report along with press releases distributed throughout the year.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters